Ab170576

antibody from Aladdin Scientific Corporation

Targeting: DLL3 SCDO1

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Functional assay (Data presented on provider website)

Antibody Data

Product number

Ab170576

Provider

Aladdin Scientific Corporation

Product name

Rovalpituzumab (anti-DLL3)

Antibody type

Recombinant

Description

Rovalpituzumab (anti-DLL3) is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab (anti-DLL3) can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab (anti-DLL3) has activity against small cell lung cancer (SCLC).Purity：>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg

Reactivity

Human

Conjugate

Unconjugated

Vial size

10mg,1mg,5mg

Concentration

Lot by Lot

Storage

Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.